Pasithea Therapeutics Corp
NASDAQ:KTTA
| Market Cap (Intraday) | 19.15M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.88 |
| 50-Day MA | $1.14 |
| 200-Day MA | N/A |
Pasithea Therapeutics Corp Stock, NASDAQ:KTTA
1111 Lincoln Road, Suite 500, Miami Beach, Florida 33139
United States of America
Phone: +1.702.514.4174
Number of Employees: 3
Description
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.